BC
INSM icon

Bayforest Capital’s Insmed INSM Stock Holding History

Bayforest Capital’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$70.7K Buy
663
+337
+103% +$40.8K 0.07% 529
2026
Q1 		$53.3K Sell
326
-1,095
-77% -$168K 0.06% 541
2025
Q4 		$247K Buy
+1,421
New +$259K 0.18% 214
2025
Q3 		– Sell
-4,098
Closed -$412K – 826
2025
Q2 		$412K Sell
4,098
-2,956
-42% -$226K 0.18% 228
2025
Q1 		$538K Buy
7,054
+5,067
+255% +$388K 0.23% 145
2024
Q4 		$137K Buy
+1,987
New +$143K 0.17% 228

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Bayforest Capital's INSM Position: Q2 2026 in Review

Bayforest Capital increased its Insmed (INSM) stake by 103% in Q2 2026, buying an estimated $40.8K and bringing the position to 663 shares worth $70.7K. The position accounts for 0.07% of the portfolio, ranked #529.

Bayforest Capital first reported a position in INSM in Q4 2024 and has held it in 6 quarters since. The position peaked at $538K in Q1 2025. 666 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Bayforest Capital held 663 shares of Insmed worth $70.7K as of Q2 2026.
  • Bayforest Capital bought 337 Insmed shares in Q2 2026, an estimated $40.8K.
  • Insmed made up 0.07% of Bayforest Capital's portfolio in Q2 2026, its #529 holding.
  • Bayforest Capital first reported a position in Insmed in Q4 2024 and has held it in 6 quarters since.
  • Bayforest Capital's Insmed position peaked at $538K in Q1 2025.
  • 666 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Bayforest Capital's 13F filing for Q2 2026, filed 5 Aug 2026.